Community News

LOS ANGELES--(BUSINESS WIRE)-- #COVID19--The Entertainment Industry Response (EIR) is a broad collection of the leading professionals and companies with expertise in entertainment production. We routinely coordinate and execute the manufacture, rental, logistics, transportation, and installation of massive amounts of equipment and temporary structures for events around the world. We are known for our unique ability to do this in record time. “EIR is a one-stop-shop for state and local […]

HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)-- #lsintelligence--Medical Devices & Diagnostics (MD&D) companies know they are being impacted by the current pandemic and are seeking independent research to quantify how much their markets will decline or increase, how long the recovery will take, and what factors will determine that recovery. A new surveillance tool to track the Impact of COVID-19 on medical devices & diagnostics markets is now available through research firm Life Science […]

IRVINE, Calif.--(BUSINESS WIRE)--AIVITA Biomedical, Inc., a biotechnology company specializing in innovative cell therapy applications, announced today updated survival data from a year-end analysis of its ongoing Phase 2 clinical trial of AV-GBM-1 in patients with newly diagnosed glioblastoma (GBM). In the analysis, the overall survival rate at both 12 and 15 months is 76% in AV-GBM-1-treated patients (n=50), compared to overall survival of 61% at 12 months and 48% at 15 months in control pati

LOS ANGELES--(BUSINESS WIRE)--T-Cure Bioscience, Inc., a privately held company focused on developing autologous T cell receptor (TCR) therapy products for the treatment of solid tumors, today announced that the Company has entered into an exclusive, worldwide license with the National Cancer Institute (NCI) for intellectual property related to a TCR-based product candidate for the treatment of tumors expressing Kita-Kyushu lung cancer antigen 1 (KK-LC-1), for the treatment of KK-LC-1-expressin

LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- #INDstatus--PharmaCyte has entered into an exclusive license agreement for a unique COVID-19 diagnostic kit to develop and sell in the U.S., Canada and beyond.

IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, today announced that Chief Executive Officer Raymond W. Cohen is scheduled for a virtual fireside chat at the Needham Healthcare Conference on Wednesday, April 15 at 1:30pm ET and will be available for virtual meetings […]

NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- #Coronavirus--California Cryotherapy Manufacturer Responds to Desperate Call from New York Hospital for Ventilator Hoses to Combat COVID-19

LOS ANGELES--(BUSINESS WIRE)-- #MusicCares--Triller Donates 150,000 N95 Respirator and Surgical Masks to the City of Los Angeles for First Responders and Essential Workers

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced a new collaboration with a large pharmaceutical partner to enhance its HTPK Simulation Module in ADMET Predictor.

IRVINE, Calif. & BETHLEHEM, Pa.--(BUSINESS WIRE)--St. Luke's is using Masimo SafetyNet™ to monitor in-hospital patients as the network seeks solutions to care for the surge of COVID-19 patients.

IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, today announced that it will release financial results for the first quarter of 2020 after the market closes on Tuesday, May 5, 2020. Raymond W. Cohen, CEO of Axonics said, “We look forward to sharing our Q1 […]

IRVINE, Calif.--(BUSINESS WIRE)--Endologix, Inc. (the “Company”) (NASDAQ: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that its preliminary unaudited revenue for the first quarter ended March 31, 2020 is expected to be approximately $28.5 million. Total cash, cash equivalents, and restricted cash as of March 31, 2020 are expected to be approximately $42.4 million, including approximately $10.5 million outstanding under the […]

VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)--AVITA Medical Provides Preliminary Top Line Results for the Third Quarter and COVID-19 Update

IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, today announced the submission of a premarket approval (“PMA”) supplement to the U.S. Food & Drug Administration (“FDA”) for the purpose of gaining full-body magnetic resonance imaging […]

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)-- #diagnostics--Medical Devices & Diagnostics (MD&D) companies know they are being impacted by the current pandemic and are seeking independent research to quantify how much their markets will decline or increase, how long the recovery will take, and what factors will determine that recovery. A new study from Health Research International (HRI) and Life Science Intelligence (LSI) will be released within hours of this announcement. The report, […]

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced today that it will report 2nd quarter fiscal year 2020 financial results on April 9, 2020, with a webcast at 4:15 p.m. EDT.

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced today it has acquired Lixoft of Paris, adding Monolix Suite to its software offerings and an established European presence.

SANTA MONICA, Calif. & NEWARK, Calif.--(BUSINESS WIRE)--Kite, a Gilead Company (Nasdaq: GILD), and Teneobio, Inc. announced the companies have entered into a license and collaboration agreement through which Kite will receive exclusive rights to certain antibodies directed to B-cell maturation antigen (BCMA). The fully human variable heavy chain of one such antibody is currently undergoing clinical evaluation in a chimeric antigen receptor (CAR) format for the treatment of patients with […]

LOS ANGELES--(BUSINESS WIRE)-- #artificialintelligence--Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™, announced today that it completed the first quarter of 2020 with encouraging business results. New business orders confirmed in the first quarter are comparable with the 12-month results for the entire 2019. In addition to strong recurring adoption by its existing user […]